SCHEMBL13766136

SCHEMBL13766136

C=CCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N1CCC[C@H]1C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 10/20 0.47
ITGA2B P08514 10/20 0.47
F2 P00734 1/20 0.45
PRSS1 P07477 1/20 0.45
HDAC1 Q13547 2/20 0.42
HDAC4 P56524 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
ACE P12821 1/20 0.40
CMA1 P23946 4/20 0.39
CTRC Q99895 2/20 0.39
HDAC8 Q9BY41 1/20 0.39
TGM2 P21980 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8225015 0.91 ACE (0.49) ITGB3ITGA2BF2PRSS1HDAC1
SCHEMBL8005012 0.90 ITGB3 (0.45) ITGB3ITGA2BF2PRSS1HDAC1
SCHEMBL8223113 0.88 ITGB3 (0.43) ITGB3ITGA2BF2PRSS1HDAC1
SCHEMBL13924274 0.88 HDAC1 (0.46) ITGB3ITGA2BF2PRSS1HDAC1
SCHEMBL12784960 0.87 ITGB3 (0.47) ITGB3ITGA2BF2PRSS1HDAC1
SCHEMBL7409155 0.86 CTSK (0.50) ITGB3ITGA2BF2PRSS1ACE
SCHEMBL7409158 0.86 CTSK (0.50) ITGB3ITGA2BF2PRSS1ACE
SCHEMBL12771027 0.85 HDAC4 (0.41) ITGB3ITGA2BF2PRSS1HDAC1
SCHEMBL8273133 0.85 HDAC1 (0.41) ITGB3ITGA2BF2PRSS1HDAC1
SCHEMBL883194 0.84 ITGB3 (0.44) ITGB3ITGA2BF2PRSS1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1680137-B1 Macrocyclic carboxylic acid and acylsulfonamide compound as inhibitor of HCV replication HOFFMANN LA ROCHE (CH) 2012-11-21 EP disclosed
WO-2009080542-A1 PROCESS FOR THE PREPARATION OF A MACROCYCLE F. HOFFMANN-LA ROCHE AG (CH) 2009-07-02 WO disclosed
WO-2008057873-A2 INHIBITORS OF HEPATITIS C VIRUS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-15 WO disclosed